|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jerjes W, Upile T, Petrie A, Riskalla A,
Hamdoon Z, Vourvachis M, Karavidas K, Jay A, Sandison A, Thomas GJ,
et al: Clinicopathological parameters, recurrence, locoregional and
distant metastasis in 115 T1-T2 oral squamous cell carcinoma
patients. Head Neck Oncol. 2:92010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carvalho AL, Nishimoto IN, Califano JA and
Kowalski LP: Trends in incidence and prognosis for head and neck
cancer in the United States: A site-specific analysis of the SEER
database. Int J Cancer. 114:806–816. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahmad A, Wang Z, Kong D, Ali S, Li Y,
Banerjee S, Ali R and Sarkar FH: FoxM1 down-regulation leads to
inhibition of proliferation, migration and invasion of breast
cancer cells through the modulation of extra-cellular matrix
degrading factors. Breast Cancer Res Treat. 122:337–346. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gemenetzidis E, Bose A, Riaz AM, Chaplin
T, Young BD, Ali M, Sugden D, Thurlow JK, Cheong SC, Teo SH, et al:
FOXM1 upregulation is an early event in human squamous cell
carcinoma and it is enhanced by nicotine during malignant
transformation. PLoS One. 4:e48492009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lam EW, Brosens JJ, Gomes AR and Koo CY:
Forkhead box proteins: Tuning forks for transcriptional harmony.
Nat Rev Cancer. 13:482–495. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sorlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tian S, Wang C and An MW: Test on
existence of histology subtype-specific prognostic signatures among
early stage lung adenocarcinoma and squamous cell carcinoma
patients using a Cox-model based filter. Biol Direct. 10:152015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu CP, Yu S, Shi L, Wang S, Li ZX, Wang
YH, Sun CJ and Liang J: FoxM1 promotes epithelial-mesenchymal
transition of hepatocellular carcinoma by targeting Snai1. Mol Med
Rep. 16:5181–5188. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park HJ, Costa RH, Lau LF, Tyner AL and
Raychaudhuri P: Anaphase-promoting complex/cyclosome-CDH1-mediated
proteolysis of the forkhead box M1 transcription factor is critical
for regulated entry into S phase. Mol Cell Biol. 28:5162–5171.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raychaudhuri P and Park HJ: FoxM1: A
master regulator of tumor metastasis. Cancer Res. 71:4329–4333.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leung TW, Lin SS, Tsang AC, Tong CS, Ching
JC, Leung WY, Gimlich R, Wong GG and Yao KM: Over-expression of
FoxM1 stimulates cyclin B1 expression. FEBS Lett. 507:59–66. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koo CY, Muir KW and Lam EW: FOXM1: From
cancer initiation to progression and treatment. Biochim Biophys
Acta. 1819:28–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma J, Qi G, Xu J, Ni H, Xu W, Ru G, Zhao
Z, Xu W and He X: Overexpression of forkhead box M1 and
urokinase-type plasminogen activator in gastric cancer is
associated with cancer progression and poor prognosis. Oncol Lett.
14:7288–7296. 2017.PubMed/NCBI
|
|
16
|
Jiang LZ, Wang P, Deng B, Huang C, Tang
WX, Lu HY and Chen HY: Overexpression of Forkhead Box M1
transcription factor and nuclear factor-κB in laryngeal squamous
cell carcinoma: A potential indicator for poor prognosis. Hum
Pathol. 42:1185–1193. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abdeljaoued S, Bettaieb I, Nasri M, Adouni
O, Goucha A, El Amine O, Boussen H, Rahal K and Gamoudi A:
Overexpression of FOXM1 Is a potential prognostic marker in male
breast cancer. Oncol Res Treat. 40:167–172. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wittekind C and Oberschmid B: TNM
classification of malignant tumors 2010: General aspects and
amendments in the general section. Pathologe. 31:333–334, 336-338.
2010.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim HE, Krug MA, Han I, Ensley J, Yoo GH,
Forman JD and Kim HR: Neutron radiation enhances cisplatin
cytotoxicity independently of apoptosis in human head and neck
carcinoma cells. Clin Cancer Res. 6:4142–4147. 2000.PubMed/NCBI
|
|
20
|
Patel V, Ramesh A, Traicoff JL, Baibakov
G, Emmert-Buck MR, Gutkind JS and Knezevic V: Profiling EGFR
activity in head and neck squamous cell carcinoma by using a novel
layered membrane Western blot technology. Oral Oncol. 41:503–508.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiao C, Wang L, Zhu L, Zhang C and Zhou J:
Secreted frizzledrelated protein 2 is epigenetically silenced and
functions as a tumor suppressor in oral squamous cell carcinoma.
Mol Med Rep. 10:2293–2298. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu J, Wu YN, Zhang W, Zhang XM, Ding X,
Li HQ, Geng M, Xie ZQ and Wu HM: Monocarboxylate transporter 4
facilitates cell proliferation and migration and is associated with
poor prognosis in oral squamous cell carcinoma patients. PLoS One.
9:e879042014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu Z, Xu X, Yu Y, Graham M, Prince ME,
Carey TE and Sun D: Silencing heat shock protein 27 decreases
metastatic behavior of human head and neck squamous cell cancer
cells in vitro. Mol Pharm. 7:1283–1290. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang IC, Chen YJ, Hughes D, Petrovic V,
Major ML, Park HJ, Tan Y, Ackerson T and Costa RH: Forkhead box M1
regulates the transcriptional network of genes essential for
mitotic progression and genes encoding the SCF (Skp2-Cks1)
ubiquitin ligase. Mol Cell Biol. 25:10875–10894. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nandi D, Cheema PS, Jaiswal N and Nag A:
FoxM1: Repurposing an oncogene as a biomarker. Semin Cancer Bilo.
52:74–84. 2018. View Article : Google Scholar
|
|
26
|
Hwang S, Mahadevan S, Qadir F, Hutchison
IL, Costea DE, Neppelberg E, Liavaag PG, Waseem A and Teh MT:
Identification of FOXM1-induced epigenetic markers for head and
neck squamous cell carcinomas. Cancer. 119:4249–4258. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Teh MT, Gemenetzidis E, Chaplin T, Young
BD and Philpott MP: Upregulation of FOXM1 induces genomic
instability in human epidermal keratinocytes. Mol Cancer. 9:452010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tosi GM, Marigliani D, Romeo N and Toti P:
Disease pathways in proliferative vitreoretinopathy: An ongoing
challenge. J Cell Physiol. 229:1577–1583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Casaroli-Marano RP, Pagan R and Vilaró S:
Epithelial-mesenchymal transition in proliferative
vitreoretinopathy: Intermediate filament protein expression in
retinal pigment epithelial cells. Invest Ophthalmol Vis Sci.
40:2062–2072. 1999.PubMed/NCBI
|
|
30
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen W, Yi JK, Shimane T, Mehrazarin S,
Lin YL, Shin H, Kim RH, Park NH and Kang MK: Grainyhead-like 2
regulates epithelial plasticity and stemness in oral cancer cells.
Carcinogenesis. 37:500–510. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thierauf J, Veit JA and Hess J:
Epithelial-to-mesenchymal transition in the pathogenesis and
therapy of head and neck cancer. Cancers (Basel). 9(pii): E762017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bao B, Wang Z, Ali S, Kong D, Banerjee S,
Ahmad A, Li Y, Azmi AS, Miele L and Sarkar FH: Over-expression of
FoxM1 leads to epithelial-mesenchymal transition and cancer stem
cell phenotype in pancreatic cancer cells. J Cell Biochem.
112:2296–2306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ishida T, Hijioka H, Kume K, Miyawaki A
and Nakamura N: Notch signaling induces EMT in OSCC cell lines in a
hypoxic environment. Oncol Lett. 6:1201–1206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakamura S, Hirano I, Okinaka K, Takemura
T, Yokota D, Ono T, Shigeno K, Shibata K, Fujisawa S and Ohnishi K:
The FOXM1 transcriptional factor promotes the proliferation of
leukemia cells through modulation of cell cycle progression in
acute myeloid leukemia. Carcinogenesis. 31:2012–2021. 2010.
View Article : Google Scholar : PubMed/NCBI
|
